Cargando…
Glycoproteomics-Based Identification of Cancer Biomarkers
Protein glycosylation is one of the most common posttranslational modifications in mammalian cells. It is involved in many biological pathways and molecular functions and is well suited for proteomics-based disease investigations. Aberrant protein glycosylation may be associated with disease process...
Autores principales: | Kim, Evelyn H., Misek, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195811/ https://www.ncbi.nlm.nih.gov/pubmed/22084691 http://dx.doi.org/10.1155/2011/601937 |
Ejemplares similares
-
Protein Biomarkers for the Early Detection of Breast Cancer
por: Misek, David E., et al.
Publicado: (2011) -
Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery
por: Doud, Emma H., et al.
Publicado: (2023) -
Glycoproteomic identification of novel plasma biomarkers for oral cancer
por: Chang, Shu-Chieh, et al.
Publicado: (2019) -
Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
por: Zhang, Ying, et al.
Publicado: (2014) -
Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review
por: Zhong, Li, et al.
Publicado: (2021)